Abstract
Anaplastic large cell lymphoma (ALCL) arising from breast tissue is an extremely rare condition and malignancies associated with implants are even rarer. The authors discuss an overview of ALCL and its characteristics. Diagnosis with the presenting features that should raise a suspicion for ALCL are outlined, along with some of the recommended diagnostic tests and treatment. Accurate diagnosis and complete surgical treatment is important for definitive treatment of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Keech JA, Creech BJ (1997) Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 100(2):554–555
Zakhary JM, Hamidian Jahromi A, Chaudhery S, Kim M (2013) Anaplastic large cell lymphoma in the setting of textured breast implant: a call for patients and physicians education. J La State Med Soc 165(1):26–29
De Silva IM, Teague JA, Blake WE (2013) Breast implant associated anaplastic large cell lymphoma: a case report and reconstructive option. J Plast Reconstr Aesthet Surg 66(12):1773–1776
Smith TJ, Ramsaroop R (2012) Breast implant related anaplastic large cell lymphoma presenting as late onset peri-implant effusion. Breast 21(1):102–104
U.S. Food and Drug Administration (2011) Anaplastic large cell lymphoma (ALCL) in women with breast implants: preliminary FDA findings and analyses. http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm240000.htm. Accessed 6/19/14
Kim B, Roth C, Chung KC, Young VL, van Busum K, Schnyer C, Mattke S (2011) Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg 127(6):2141–2150
Kim B, Roth C, Young VL, Chung KC, van Busum K, Schnyer C, Mattk S (2011) Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process. Plast Reconstr Surg 128(3):629–639
Story SK, Schowalter MK, Geskin LJ (2013) Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders. Oncologist 18(3):301–307
Ferreri AJM, Govi S, Pileri SA, Savage KJ (2013) Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol 85(2):206–215
Lee M, Cooper B, Becker D (2012) Keeping abreast of axillary masses. Lancet 380(9852):1530
Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, Amin MB, Haideri N, Bhagat G, Brooks GS, Shifrin DA, O'Malley DP, Cheah CY, Bacchi CE, Gualco G, Li S, Keech JA Jr, Hochberg EP, Carty MJ, Hanson SE, Mustafa E, Sanchez S, Manning JT Jr, Xu-Monette ZY, Miranda AR, Fox P, Bassett RL, Castillo JJ, Beltran BE, de Boer JP, Chakhachiro Z, Ye D, Clark D, Young KH, Medeiros LJ (2014) Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol 32(2):114–120
Ivaldi C, Perchenet AS, Jallut Y, Casanova D (2013) À propos de deux cas de lymphome mammaire sur coque périprothétique : un diagnostic difficile; une pathologie méconnue. Ann Chir Plast Esthet 58(6):688–693
Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A (2008) Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 21(4):455–463
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ibrahim, A.E., Atiyeh, B.S., Sarhane, K.A., Clemens, M. (2016). Breast Implant Associated Anaplastic Large Cell Lymphoma (ALCL): Current Recommendations on Diagnosis and Treatment Strategies. In: Shiffman, M. (eds) Breast Reconstruction. Springer, Cham. https://doi.org/10.1007/978-3-319-18726-6_147
Download citation
DOI: https://doi.org/10.1007/978-3-319-18726-6_147
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18725-9
Online ISBN: 978-3-319-18726-6
eBook Packages: MedicineMedicine (R0)